1 / 31

Coagulation-Anticoagulation Balance and Imbalance of Haemostatic System

Coagulation-Anticoagulation Balance and Imbalance of Haemostatic System. Clinical Significances of Hemostasis. Bleeding Disorders. Hemophilia A. VIII. Deficiency in vitamin K. von Willebrand disease. Deficiencies in factor IX. Antithrombin deficiency. Thromboembolism. Role of Vitamin K.

saddam
Download Presentation

Coagulation-Anticoagulation Balance and Imbalance of Haemostatic System

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Coagulation-Anticoagulation Balance and Imbalance of Haemostatic System

  2. Clinical Significances of Hemostasis Bleeding Disorders Hemophilia A VIII Deficiency in vitamin K von Willebrand disease Deficiencies in factor IX Antithrombin deficiency Thromboembolism

  3. Role of Vitamin K Vitamin K-dependent carboxylase Carboxylated prozymogens Inactive prozymogen (Clotting factors II, VII, IX, X, protein C and S)

  4. Contents • Concepts: Disseminated Intravascular Coagulation (DIC), Shwartzman reaction • Conditions and predisposing factor • Mechanism of DIC • Clinical and laboratory findings • Prevention and treatment principle

  5. Disseminated Intravascular Coagulation (DIC)

  6. Definition A disorder of widespread micro-vascular thrombosis caused by activation of coagulation with or without bleeding caused by secondary fibrinolytic activation.

  7. Meningococcemia on the calves

  8. Meningococcemia associated purpura

  9. Case Presentation A 23-year woman, induced abortion, delivered one dead fetus. After parturition, profluvium sanguis from vagina constantly. 14 hrs after parturition, convulsion and obnubilation developed. Large ecchymosis on extremities and abdomen. BP: undetectable; platelet: 7,000; BT: 1 min; CT: 1min; PT: 18 sec; Fib:1.1g/L; 3P test (+)

  10. Conditions Causing DIC Syndromes Infections (most common): Acute DIC: Bacteria and their toxins, fungi, viruses, rickettsiae;Chronic DIC: Any chronic infection (eg, tuberculosis, abscesses, osteomyelitis)Malignancy: Acute DIC: Acute promyelocytic leukemia, acute monocytic leukemia, disseminated prostatic carcinomaChronic DIC: Lung, breast, gastrointestinal malignancy Obstetrical complications: Acute DIC: Abruption placenta, abortions (especially therapeutic abortions), amniotic fluid embolism, hemorrhagic shockChronic DIC: Dead fetus syndromeTrauma:Acute DIC: Massive tissue destruction, brain damage Vascular disease: Acute DIC: Brain infarction or hemorrhageChronic DIC: Aortic aneurysm, giant hemangiomaVenoms: Acute DIC: Snake, spider (rare)Others: Acute DIC: Heparin-induced thrombocytopenia with thrombosis (HITT), purpura in newborns (homozygous protein C deficiency)

  11. DIC Predisposing Factors Impaired clearance system: Liver, mononuclear phagocyte Shwartzman reaction; Hypercoagulable state: e.g., pregnancy; Disorder of microcirculation: e.g., giant hemangioma.

  12. Infection Childbirth, dead fetus, or surgery Cancer Poisonous snake Severe head injury Endothelial damage; tissue damage; director activation of factor X, damage of blood cells Hypercoagulable stage Excessive clotting Hypocoagulable stage Clotting factors and platelets are depleted Secondary fibrinolytic stage Excessive bleeding occurs

  13. Roel of Endothelial Cell

  14. Scanning electron micrograph of moderately active platelet Pseudopods

  15. Intrinsic Extrinsic The “Cascade” theory of Coagulation

  16. Anticoagulation System Cells Macrophage, endothelial cell, etc Molecules Serine-containing enzyme inhibitors; Protein C system; Tissue factor pathway inhibitor; Fibrinolytic system, etc

  17. Controls at Thromblin Level Antithrombin III is the most important Others: a2-macroglobulin heparin cofactor II a1-antitrypsin

  18. Protein C Thrombomodulin Thrombin Activated Protein C Protein S Degradation of Va, VIIIa Resistance to activated protein C in patients with thromboembolism

  19. tPA: tissue plasminogen activator; PAI-1: plasminogen activator inhibitor; AP: antiplasmin

  20. VEC TFPI tPA,uPA PAI PC, PS, TM Plasmin Heparin+ATIII FDPS TFPI: tissue factor pathway inhibitor; PC: protein C; PS: protein S; TM: thrombodulin; ATIII: antithrombin III; tPA:tissue plasminogen activator; uPA:urokinase; FDPS: fibrin degradation products; plasminogen activator-inhibitors type 1 (PAI-1);VEC: vascular endothelial cell.

  21. Clinical and Laboratory Findings in DIC Clinical findings • Bleeding at multiple sites (Ecchymoses of skin, mucous membranes; Visceral hemorrhage) • Organ dysfunction (Waterhouse-Friderichsen syndrome; Sheehan’s syndrome) • Shock • Hemolytic anemia(microangiopathic hemolytic anemia)

  22. Integumentary system: Widespread hemorrhage and vascular lesions, Oozing from puncture sites, incision, mucous membranes, irregular-shaped cyanotic patches Central nervous system: Subarachnoid hemorrhage, altered state of consciousness Gastrointestinal system: Occult bleeding to massive gastrointestinal bleeding; abdominal distention; malaise, weakness Pulmanary system Renal system: hematuria, oliguria, renal failure

  23. Laboratory abnormalities • Coagulation abnormalities: prolonged prothrombin time, activated partial thromboplastin time, thrombin time; decreased fibrinogen levels; increased levels of FDP (eg, “3P” test, D-dimer) • Platelet count decreased as a rule but may be falling from a higher level yet still be normal • Schistocyte

  24. Plasma Protamin Paracoagulation Test (“3P”test) FDP+Fibrin Protamin Fibrin Aggregation FDP+Protamin

  25. Schistocyte

  26. Treatment Principles Treat the underlying disease 1. Avoid delay2. Treat vigorously (eg, shock, sepsis, obstetrical problems)

  27. Manage the DIC       Blood components as needed       Fresh frozen plasma       Platelet transfusions         Anticoagulants after bleeding risk is corrected

  28. Summary

  29. Thank you

More Related